Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: October 31, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 26, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration.
Journal: Blood advances
Published: May 15, 2025
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Journal: British journal of haematology
Published: March 01, 2024
Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability.
Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability.
Journal: Frontiers in oncology
Published: January 24, 2023
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Journal: International journal of molecular sciences
Published: May 13, 2022
Last Updated: 09/26/2026